Trans Arterial Chemoembolization Tace | List of Frontiers open access articles

Systematic Review

Published on 10 Oct 2023

Unresectable intrahepatic cholangiocarcinoma: TARE or TACE, which one to choose?

in Gastroenterology and Cancer

Maria Adriana Cocozza
Lorenzo Braccischi
Antonio De Cinque
Antonio Bruno
Alberta Cappelli
Matteo Renzulli
Antonello Basile
Massimo Venturini
Pierleone Lucatelli
Francesco Modestino

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1270264

6,087 views
4 citations

Original Research

Published on 18 Oct 2021

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients

in Pharmacology of Anti-Cancer Drugs

Juanfang Liu
Zhen Li
Wenguang Zhang
Huibin Lu
Zhanguo Sun
Guozheng Wang
Xinwei Han

Frontiers in Pharmacology

doi 10.3389/fphar.2021.709060

5,090 views
55 citations

Case Report

Published on 19 Mar 2021

Case Report: Cytoreductive Surgery and HIPEC Associated With Liver Electrochemotherapy in a Cholangiocarcinoma Patient With Peritoneal Carcinomatosis and Liver Metastasis Case Report

in Surgical Oncology

Mauro Stefano
Enrico Prosperi
Paola Fugazzola
Beatrice Benini
Marcello Bisulli
Federico Coccolini
Costantino Mastronardi
Alessandro Palladino
Matteo Tomasoni
Vanni Agnoletti

Frontiers in Surgery

doi 10.3389/fsurg.2021.624817

6,591 views
4 citations

Original Research

Published on 16 May 2023

The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report

in Cancer Immunity and Immunotherapy

Chunyang Mu
Junyi Shen
Xinrui Zhu
Wei Peng
Xiaoyun Zhang
Tianfu Wen

Frontiers in Oncology

doi 10.3389/fonc.2023.1096955

2,717 views
4 citations

Original Research

Published on 23 May 2022

Pretreatment Computed Tomography-Based Machine Learning Models to Predict Outcomes in Hepatocellular Carcinoma Patients who Received Combined Treatment of Trans-Arterial Chemoembolization and Tyrosine Kinase Inhibitor

in Bionics and Biomimetics

Qianqian Ren
Peng Zhu
Changde Li
Meijun Yan
Song Liu
Chuansheng Zheng
Xiangwen Xia

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2022.872044

4,946 views
15 citations

Original Research

Published on 16 Jul 2021

Efficacy and Prognostic Factors of Trans-Arterial Chemoembolization Combined With Stereotactic Body Radiation Therapy for BCLC Stage B Hepatocellular Carcinoma

in Radiation Oncology

Changchen Jiang
Shenghua Jing
Han Zhou
Aomei Li
Xiangnan Qiu
Xixu Zhu
Zetian Shen

Frontiers in Oncology

doi 10.3389/fonc.2021.640461

3,748 views
4 citations

Articles

Unresectable intrahepatic cholangiocarcinoma: TARE or TACE, which one to choose?

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients

Case Report: Cytoreductive Surgery and HIPEC Associated With Liver Electrochemotherapy in a Cholangiocarcinoma Patient With Peritoneal Carcinomatosis and Liver Metastasis Case Report

The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report

Pretreatment Computed Tomography-Based Machine Learning Models to Predict Outcomes in Hepatocellular Carcinoma Patients who Received Combined Treatment of Trans-Arterial Chemoembolization and Tyrosine Kinase Inhibitor

Efficacy and Prognostic Factors of Trans-Arterial Chemoembolization Combined With Stereotactic Body Radiation Therapy for BCLC Stage B Hepatocellular Carcinoma